Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: life extension

It’s really the first widely reviewed book by a prominent writer that specifically covers modern #transhumanism. While it’s done from a non-transhumanist perspective, it’s great reading and a BIG step forward for transhumanism and life extension (we need books about the movement that target laypeople). The last chapter is dedicated to the Immortality Bus and my presidential campaign. Additionally, many transhumanists and their work are covered in this comprehensive book. Grab a copy! https://www.amazon.com/Be-Machine-Adventures-Utopians-Futurists/dp/0385540418/ref=tmm_hrd_swatch_0?_encoding=UTF8&qid=1488391799&sr=8-1

Read more

Support LEAF/Lifespan.io with a geeky science t-shirt and help us to continue creating quality content, engaging science and supporting research.

Trust me, I’m a “Biologist” experiments with fun and also tries to do a little good from time to time. Today we run a T-shirt campaign – to support another non-profit: LEAF (www.lifespan.io)! Because we’re deep into aging research.

Read more

Are you an avid supporter of aging research and a keen longevity activist?
The Biogerontology Research Foundation is offering select summer internships for talented individuals. You’d join a passionate and supportive team in researching diagnostic, prognostic, and therapeutic strategies; advising a panel of investors in developing a roadmap to promote longevity science and related technologies across the globe.

The advertised positions are 3 month internships, with the possibility of continuing afterwards. Free accommodation will be provided for in London, alongside a negotiable salary.

The Biogerontology Research Foundation is a UK based think tank dedicated to aging research and accelerating its application worldwide.

Apply to: [email protected]

Are you an avid supporter of aging research and a keen longevity activist?

The Biogerontology Research Foundation is offering select summer internships for talented individuals. You €™d join a passionate and supportive team in researching diagnostic, prognostic, and therapeutic strategies; advising a panel of investors in developing a roadmap to promote longevity science and related technologies across the globe.

Read more

Slate book columnist Mark O’Connell’s new book To Be a Machine, which is specifically about #transhumanism, is out tomorrow. So there’s a ton of reviews out in major media. The last chapter in the book is about my work. Here are 3 reviews just out on the book. ALSO, I highly encourage you to BUY the book to help transhumanism grow. Mark’s book is the first book specifically on the movement with this kind of international attention, and the better the book does the first week, the more people will know about transhumanism: http://www.theverge.com/2017/2/25/14730958/transhumanism-mark-oconnell-interview-cyborg-hacker-futurist-biohackers &

http://www.theglobeandmail.com/arts/books-and-media/book-reviews/bonnie-rochmans-the-gene-machine-and-mark-oconnells-to-be-a-machine-reviewed-matters-of-life-and-death/article34127614/ &

Mark O’Connell Doesn’t Want to Be a Cyborg: The Millions Interview

The strangest place writer Mark O’Connell has ever been to is the Alcor Life Extension Foundation — where dead bodies are preserved in tanks filled with nitrogen, in case they can be revived with future technology. “There was a floor with the stainless steel cylinders and all these bodies contained within them and corpses and severed heads,” he tells The Verge. “That imagery is something that I will take with me to a grave, whether that’s a refrigerated cylinder or an actual grave.”

O’Connell, 37, visited Alcor while writing To Be a Machine, which comes out February 28th. The nonfiction book delves into the world of transhumanists, or people who want to transcend the limits of the human body using technology. Transhumanists want to be stronger and faster; they want to be cyborgs. And they want to solve the problem of death, whether by freezing their bodies through cryonics or uploading their consciousnesses. Transhumanists have been around since at least the 1980s, but have become more visible in the past decade as technology advances have made these ideas seem more feasible and less like sci-fi.

Read more

For all of my friends working in the fight for the cure for cancer; meet the world’s oldest full blown research institute on cancer. Oak Ridge Associate University (ORAU) was established in 1946 to study the fall out of the A-Bomb — its labs, its workers, and its victims in Japan. Many private citizens living in the surrounding areas of Oak Ridge TN, Los Alamos NM, Hanford WA where the enrichment and testing existed where also (unfortunately) exposed, and as a result ORAU’s research was expanded in the late 40s to including civilians living in these regions.

Fast forward to today, ORAU has one of the world’s most extensive set of records on cancer, cancer fallout, treatments, etc. in the world. I highly encourage many research medical teams and labs who are working to reverse aging, precision medicine, etc. that is also targeting cancer that you may wish to connect with ORAU as they do share insights with other researchers often. I often consider ORAU like the world’s library on cancer, carcinogen, etc. that are tied to cancer.

My own family has been working with the team at ORAU since 1949. Sharing for awareness in hopes that it helps their own efforts in anti-aging, precision medicine, Quantum Biology/ Biosystems, etc.

ORAU began in 1946 when Dr. William G. Pollard established the Oak Ridge Institute for Nuclear Studies. Read a narrative history of ORAU, view a timeline of our six decades of accomplishments and meet some of the faces of our past leaders.

Read more

The Methuselah Foundation wants to extend healthy life — By advancing tissue engineering and regenerative medicine, they want to create a world where 90-year olds can be as healthy as 50-year olds—by 2030.

Donate to the Methuselah Foundation here at this link

Methuselah Foundation reviewed the progress they made over the past year. Much of what you’ll read in this year in review letter is very late-breaking, and leads us to believe that 2017 will be a very important year in medical developments. 2016 took us a broad step closer to fulfilling our mission statement to “Make 90 the New 50, by 2030”. Why can we say that? For starters, let’s look at several achievements to date that made this year so successful:

Read more

Restorative neuroscience, the study to identify means to replace damaged neurons and recover permanently lost mental or physical abilities, is a rapidly advancing scientific field considering our progressively aging society. Redirecting immature neurons that reside in specific brain areas towards the sites of brain damage is an appealing strategy for the therapy of acute brain injury or stroke. A collaborative effort between the Center for Brain Research of Medical University of Vienna and the National Brain Research Program of Hungary/Semmelweis University in Budapest revealed that some mature neurons are able to reconfigure their local microenvironment such that it becomes conducive for adult-born immature neurons to extensively migrate. Thus, a molecular principle emerges that can allow researchers to best mobilize resident cellular reserves in the adult brain and guide immature neurons to the sites of brain damage.

The adult brain has limited capacity of self-repair.

In the aging Western society, acute brain damage and chronic neurodegenerative conditions (e.g. Alzheimer’s and Parkinson’s diseases) are amongst the most debilitating diseases affecting hundreds of millions of people world-wide. Nerve cells are particularly sensitive to microenvironmental insults and their loss clearly manifests as neurological deficit. Since the innate ability of the adult human brain to regenerate is very poor and confined to its few specialized regions, a key question in present-day neurobiology is how to establish efficient strategies that can replace lost neurons, guide competent cells to the sites of injury and facilitate their functional integration to regain lost functionality. “Cell replacement therapy” thus offers frontline opportunities to design potent therapeutic interventions.

Read more